跳至主要内容
临床试验/DRKS00021184
DRKS00021184已完成不适用

Development of an senescence-associated system diagnostic kit for cancer and stroke - SASKit - SASKit

niversitätsmedizin Rostock0 个研究点目标入组 150 人开始时间: 2020年3月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Newly diagnosed Adenocarcinoma of the pancreas in the advanced or metastatic stage, no previous system therapy
  • Ischemic stroke of the supratentorial brain region before 3-10 days (definitive cerebral infarction volume> 10 ml on MRI)
  • Control person who is neither brother nor sister and has an age difference of no more than 12 years.

排除标准

  • - Age <18 years
  • - previous or current medical tumor therapy
  • - other cancer within the past 2 years
  • - previous stroke with persistent deficit
  • - myocardial infarction within the past 2 years
  • - therapeutic anticoagulation, within the past 2 years up to the time of study enrollment, for a duration of more than 1 month
  • The exclusion criteria are described in detail in our study protocol (Henze et al., BMJ open 10:e039560, 2020, PMID 33334830)

研究者

发起方
niversitätsmedizin Rostock

相似试验